Ertunc Devrim, Tok Ekrem, Dilek Umut, Pata Ozlem, Dilek Saffet
Department of Obstetrics and Gynecology, Faculty of Medicine, Mustafa Kemal University, Turkey.
Ann Saudi Med. 2004 Jul-Aug;24(4):280-3. doi: 10.5144/0256-4947.2004.280.
There is still no consensus on screening, threshold levels and treatment of gestational diabetes mellitus. Furthermore, the importance of a positive 50-g glucose screening test in patients who had a negative 100-g oral glucose tolerance test remains controversial. We investigated the impact of the 50-g glucose screening test results on neonatal outcome in pregnant women with uncomplicated pregnancies, who had no risk factors according to ACOG criteria.
Three hundred eighty-six pregnant women with singleton pregnancies were prospectively screened with 50-g glucose challenge test between 24 and 28 weeks. If the test result was >140 mg/dl, a 100-g 3-hour oral glucose tolerance test was performed. Patients with a positive screening test, but not diagnosed as gestational diabetes mellitus constituted the study group, and patients with a negative screening test constituted the control group. Cesarean rates, neonatal birth weights and complications were compared between these groups.
The cesarean delivery rates were not statistically different between the study and control groups (8.3% vs. 6.4%, P>0.05). The rates of macrosomic births were 10.0% in the study group, and 6.4% in the control group (P>0.05), but the mean birth weight (3451.67 +/- 355.70 g) in the study group was significantly higher than the mean birth weight (3296.29 +/- 365.14 g) in the control group (P=0.003). Neonatal hypoglycemia and hyperbilirubinemia was also encountered more often in babies of pregnant women with a positive 50-g glucose challenge test but negative 100-g glucose tolerance test.
Because of similarities with gestational diabetes mellitus on the basis of perinatal outcomes, the non-diabetic pregnant women with 50-g glucose screen test result over 140 mg/dl but a negative 100-g OGTT should be followed closely.
对于妊娠期糖尿病的筛查、阈值水平及治疗仍未达成共识。此外,在100克口服葡萄糖耐量试验结果为阴性的患者中,50克葡萄糖筛查试验呈阳性的重要性仍存在争议。我们调查了50克葡萄糖筛查试验结果对无合并症、根据美国妇产科医师学会(ACOG)标准无危险因素的孕妇新生儿结局的影响。
386名单胎妊娠孕妇在孕24至28周期间前瞻性地接受了50克葡萄糖耐量试验筛查。如果试验结果>140毫克/分升,则进行100克3小时口服葡萄糖耐量试验。筛查试验呈阳性但未被诊断为妊娠期糖尿病的患者构成研究组,筛查试验呈阴性的患者构成对照组。比较两组的剖宫产率、新生儿出生体重及并发症。
研究组与对照组的剖宫产率无统计学差异(8.3%对6.4%,P>0.05)。巨大儿出生率在研究组为10.0%,在对照组为6.4%(P>0.05),但研究组的平均出生体重(3451.67±355.70克)显著高于对照组的平均出生体重(3296.29±365.14克)(P=0.003)。50克葡萄糖耐量试验呈阳性但100克葡萄糖耐量试验呈阴性的孕妇所生婴儿中,新生儿低血糖和高胆红素血症也更常见。
由于基于围产期结局与妊娠期糖尿病相似,50克葡萄糖筛查试验结果超过140毫克/分升但100克口服葡萄糖耐量试验结果为阴性的非糖尿病孕妇应密切随访。